Search

Obesity-induced inflammation is a risk factor for metabolic impairment leading to diabetes and cardiovascular disease. We, and others, have shown that sex differences exist in adipose tissue (AT) and myeloid inflammatory responses to high-fat diet (HFD) and lipolysis. However, the causal cellular mechanisms behind this sexual dimorphism are not well defined. Our objective was to investigate sex differences in lipid storage and metabolism that drive sexually dimorphic inflammatory responses. C57Bl/6J mice were fed a normal diet or 60%kcal%fat (HFD) for 16 weeks. AT macrophages (ATMs) were sorted for RNA sequencing. Animals were gonadectomized (GX) prior to starting HFD and gonadal white AT (GWAT) was collected for lipidomics. To directly model androgen receptor (AR) activation, GX mice were given dihydrotestosterone (DHT) to study AR-specific effects. RNA sequencing identified upregulated genes (Lpl, Ctsb, and Cd36) linked to a metabolically-activated macrophage only in male HFD ATMs. Furthermore, pathways associated with mitochondrial depolarization and fatty acid (FA) metabolism differed significantly by sex. GWAT lipidomics identified shifts in lipid species both by sex and hormone status, and differences were also observed in acylcarnitines and saturation of ceramide species that are implicated in inflammation. In addition, males showed elevated levels of key precursor free FAs (palmitic, linoleic, and arachidonic acid) when compared to female and GX mice. DHT treatment did not completely mimic male pro-inflammatory responses but induced GWAT crown-like structures in both sexes. DHT failed to upregulate inflammatory markers (Il6 and Mcp1) but showed impaired expression of adipogenic genes (Pparg and Pgc1α) in GX mice. Altogether, our data suggest there are sex-specific alterations in GWAT lipid storage and metabolism that may drive sexually dimorphic ATM polarization, which is only partially reversed by AR activation. Disclosure R. Mohan: None. M. Varghese: None. S. Abrishami: None. K. Singer: None. Funding National Institutes of Health - NIDDK (R01DK115583)

Men have a higher risk of metabolic and cardiovascular disease than pre-menopausal women, but the mechanisms of these differences are elusive. Chronic myeloid inflammation during obesity contributes to metabolic disease risk and is significantly more robust in males. Given the paucity of data on male sex hormones contributing to macrophage responses in obesity, our objective was to understand the role of androgens in promoting obesity-induced myeloid inflammation. Male and female C57Bl/6J mice were fed a 60% high fat diet for 24 weeks. Glucose tolerance and insulin sensitivity were measured. Monocyte transfer experiments assessed sex differences in bone marrow myeloid responses to obesity independent of host sex. Gonadectomy, mice deficient of androgen receptor signaling (ARtfm) and monocyte specific androgen receptor (AR) knockout mice (LysMAR-/y) were used to model androgen deficiency. Compared to males, females had dampened inflammatory responses with reduced CD11c+ ATMs and cytokines, even with increased adiposity. RNASeq demonstrated sex differences in gene pathways of both metabolic and inflammatory activation in ATMs. Male monocytes transferred into females remained primed for pro-inflammatory response and induced an increase in adiposity. Castrated males exposed to high fat diet had impaired glucose tolerance and increased insulin sensitivity with increased adiposity and lower numbers of CD11c+ ATMs. These same findings were seen in ARtfm mice. Testosterone enhanced palmitate-stimulated myeloid colony production, and this response was dampened in castrated, ARtfm, and LysMAR-/y mice. These studies demonstrate that androgens play a critical role in enhanced metabolic dysfunction and enhanced myeloid inflammation in response to obesogenic cues. Androgen driven myeloid inflammation leads to metabolic dysfunction in a cell-autonomous manner driving sex-differences in obesity induced meta-inflammation. Disclosure C.A. Griffin: None. S. Abrishami: None. M. Varghese: None. K. Singer: None.

Men and post-menopausal women are at greater risk for cardiovascular diseases and diabetes than younger women. In obese rodent models, males exhibit profound adipose tissue macrophage (ATM) accumulation in gonadal white adipose tissue (GWAT) linked to insulin resistance, while females are protected even with enhanced adiposity. We hypothesize that these inflammatory differences may be a result of altered lipolysis responses and that females would have enhanced ATM accumulation when lipolysis is induced. Lipolysis was stimulated with a beta3 adrenergic receptor (ADRB3) agonist CL-316, 243 in C57Bl6/j male and female mice fed 16 weeks of 60% high fat diet (HFD). GWAT leukocytes were isolated after 18 h and evaluated by flow cytometry. Lipogenic, lipolytic, oxidative and inflammatory gene expression along with immunofluorescence were performed. ADRB3 activation did not alter adipose tissue weights, but significantly reduced liver weights in obese females. Obese CL treated female mice showed elevated serum free fatty acid (FFA) and triglyceride (TG) levels compared to levels induced in males. Lipid overload impaired TG storage and utilization genes- Lpl, Fasn, Acsl1, Hsl, and Glut4 expression in obese females. Lipolysis promoted appearance of crown like structures (CLS) in males and females but only induced Il6 proinflammatory cytokine and Mcp1 chemokine expression in obese female GWAT. Activated lipolysis triggered CD11c- ATM accumulation in lean females but in both obese male and female GWAT. Obese males showed a marked reduction in GWAT dendritic cells (DC) but a significant reduction in both GWAT and inguinal WAT DCs of obese females. While obese females are resistant to inflammation, this study shows that induced lipolysis elevates FFA levels, alters lipid metabolism and increased CD11c- ATMs and CLSs in obese females. Elucidating the link between lipolysis and inflammation can better explain sex differences in overall metabolic health leading to targeted treatment strategies. Disclosure M. Varghese: None. S. Abrishami: None. K. Singer: None.